DEA
IDXX icon

DoubleLine ETF Adviser’s Idexx Laboratories IDXX Stock Holding History

DoubleLine ETF Adviser’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$455K Sell
865
-117
-12% -$65.6K 0.19% 122
2026
Q1 		$552K Buy
+982
New +$630K 0.21% 110

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

DoubleLine ETF Adviser's IDXX Position: Q2 2026 in Review

DoubleLine ETF Adviser reduced its Idexx Laboratories (IDXX) stake by 12% in Q2 2026, selling an estimated $65.6K and leaving 865 shares worth $455K. The position accounts for 0.19% of the portfolio, ranked #122.

DoubleLine ETF Adviser first reported a position in IDXX in Q1 2026 and has held it in 2 quarters since. The position peaked at $552K in Q1 2026. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • DoubleLine ETF Adviser held 865 shares of Idexx Laboratories worth $455K as of Q2 2026.
  • DoubleLine ETF Adviser sold 117 Idexx Laboratories shares in Q2 2026, an estimated $65.6K.
  • Idexx Laboratories made up 0.19% of DoubleLine ETF Adviser's portfolio in Q2 2026, its #122 holding.
  • DoubleLine ETF Adviser first reported a position in Idexx Laboratories in Q1 2026 and has held it in 2 quarters since.
  • DoubleLine ETF Adviser's Idexx Laboratories position peaked at $552K in Q1 2026.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on DoubleLine ETF Adviser's 13F filing for Q2 2026, filed 14 Aug 2026.